MYGN
Myriad Genetics, Inc. (MYGN) Investor Questions
Review Myriad Genetics, Inc. (MYGN) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Myriad Genetics, Inc.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Overall BTI score
- 42
- Annual revenue
- $824.50M
- Annual net income
- $-365.90M
- Annual free cash flow
- $-25.60M
Myriad Genetics, Inc. (MYGN) Investor Questions research
Myriad Genetics, Inc. trades under the ticker MYGN. The company is classified in the Healthcare sector and the Medical - Diagnostics & Research industry.
Investors commonly review MYGN through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.